Conte E et al.PI3K p110? overexpression in idiopathic pulmonary fibrosis lung tissue and fibroblast cells: in vitro effects of its inhibition.Lab Invest 93:566-76 (2013).
Law AJ et al.Neuregulin 1-ErbB4-PI3K signaling in schizophrenia and phosphoinositide 3-kinase-p110d inhibition as a potential therapeutic strategy.Proc Natl Acad Sci U S A 109:12165-70 (2012).
Suárez-Fueyo A et al.Enhanced phosphoinositide 3-kinase d activity is a frequent event in systemic lupus erythematosus that confers resistance to activation-induced T cell death.J Immunol 187:2376-85 (2011).
Jiang X et al.Phosphoinositide 3-kinase pathway activation in phosphate and tensin homolog (PTEN)-deficient prostate cancer cells is independent of receptor tyrosine kinases and mediated by the p110beta and p110delta catalytic subunits.J Biol Chem 285:14980-9 (2010).
Pang H et al.Differential enhancement of breast cancer cell motility and metastasis by helical and kinase domain mutations of class IA phosphoinositide 3-kinase.Cancer Res 69:8868-76 (2009).
Jaiswal BS et al.Somatic mutations in p85alpha promote tumorigenesis through class IA PI3K activation.Cancer Cell 16:463-74 (2009).